165 related articles for article (PubMed ID: 38532312)
1. High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade.
Wang G; Ren X; Li J; Cui R; Zhao X; Sui F; Liu J; Chen P; Yang Q; Ji M; Hou P; Gao K; Qu Y
BMC Cancer; 2024 Mar; 24(1):385. PubMed ID: 38532312
[TBL] [Abstract][Full Text] [Related]
2. miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1.
Wang T; Zhang Y; Cui B; Wang M; Li Y; Gao K
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1394-1403. PubMed ID: 33200790
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.
Namgoong S; Cheong HS; Kim JH; Kim LH; Seo JY; Kang SG; Yoon SJ; Kim SH; Chang JH; Shin HD
PLoS One; 2018; 13(11):e0207660. PubMed ID: 30462709
[TBL] [Abstract][Full Text] [Related]
4. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
5. Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants.
Wu Y; Tong X; Tang LL; Zhou K; Zhong CH; Jiang S
Asian Pac J Cancer Prev; 2014; 15(17):7163-7. PubMed ID: 25227808
[TBL] [Abstract][Full Text] [Related]
6. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
8. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
9. Regulator of telomere elongation helicase 1 gene and its association with malignancy.
Hassani MA; Murid J; Yan J
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1735. PubMed ID: 36253342
[TBL] [Abstract][Full Text] [Related]
10. RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication.
Vannier JB; Sandhu S; Petalcorin MI; Wu X; Nabi Z; Ding H; Boulton SJ
Science; 2013 Oct; 342(6155):239-42. PubMed ID: 24115439
[TBL] [Abstract][Full Text] [Related]
11. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
Huang Y; Luo F
IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
14. TRPM2-AS inhibits the growth, migration, and invasion of gliomas through JNK, c-Jun, and RGS4.
Bao MH; Lv QL; Szeto V; Wong R; Zhu SZ; Zhang YY; Feng ZP; Sun HS
J Cell Physiol; 2020 May; 235(5):4594-4604. PubMed ID: 31637708
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
Ahmad A; Zhang W; Wu M; Tan S; Zhu T
Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
[TBL] [Abstract][Full Text] [Related]
16. RTEL1 is upregulated in colorectal cancer and promotes tumor progression.
Wu Z; Gong Z; Li C; Huang Z
Pathol Res Pract; 2023 Dec; 252():154958. PubMed ID: 37988793
[TBL] [Abstract][Full Text] [Related]
17. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
18. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
19. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
20. RTEL1 tagging SNPs and haplotypes were associated with glioma development.
Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G
Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
